Filing Details
- Accession Number:
- 0001457612-22-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-26 16:11:58
- Reporting Period:
- 2022-05-26
- Accepted Time:
- 2022-05-26 16:11:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1457612 | Genocea Biosciences Inc. | GNCA | Biological Products, (No Disgnostic Substances) (2836) | 510596811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1696784 | Diantha Duvall | C/O Genocea Biosciences, Inc. 100 Acorn Park Drive, 5Th Floor Cambridge MA 02140 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-26 | 24,407 | $0.08 | 76,743 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.0765 to $0.0766, inclusive.
Billionaire Hedge Funds
